Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 14, 2025; 31(2): 99082
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.99082
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.99082
Table 2 Baseline characteristics of adenomatous polyp cohort in training and validation group
Variables | Total (n = 596) | Training group (n = 432) | Validation group (n = 164) | χ2/t/Z | P value |
Male, n (%) | 324 (54.4) | 90 (54.9) | 234 (54.2) | 0.024 | 0.876 |
Age (year), mean ± SD | 53.02 ± 11.14 | 53.04 ± 11.24 | 52.96 ± 10.91 | 0.089 | 0.929 |
BMI (kg/m²), mean ± SD | 25.66 ± 3.94 | 25.78 ± 3.94 | 25.31 ± 3.93 | 1.323 | 0.186 |
Alcohol, n (%) | 179 (30.0) | 127 (29.4) | 52 (31.7) | 0.302 | 0.583 |
Smoking, n (%) | 193 (32.4) | 145 (33.6) | 48 (29.3) | 1.002 | 0.317 |
Diabetes, n (%) | 154 (25.8) | 120 (27.8) | 34 (20.7) | 3.080 | 0.079 |
Hypertension, n (%) | 165 (27.7) | 120 (27.8) | 45 (27.4) | 0.007 | 0.934 |
MS, n (%) | 96 (16.1) | 69 (16.0) | 27 (16.5) | 0.021 | 0.884 |
Cirrhosis, n (%) | 285 (47.8) | 215 (49.8) | 70 (42.7) | 2.392 | 0.122 |
FPG (mmo/L), mean ± SD | 6.15 ± 2.07 | 6.23 ± 2.16 | 5.93 ± 1.85 | -1.573 | 0.116 |
HDL (mmo/L), mean ± SD | 1.33 ± 0.40 | 1.33 ± 0.41 | 1.33 ± 0.38 | 0.105 | 0.916 |
CHO (mmo/L), median (IQR) | 4.54 (3.82, 5.38) | 4.57 (3.81, 5.40) | 4.41 (3.85, 5.41) | -0.714 | 0.458 |
TG (mmo/L), mean ± SD | 1.42 ± 1.12 | 1.44 ± 1.22 | 1.35 ± 0.82 | -0.826 | 0.409 |
LDL (mmo/L), mean ± SD | 2.81 ± 0.90 | 2.75 ± 0.82 | 2.83 ± 0.93 | -0.979 | 0.382 |
TP (g/L), mean ± SD | 71.54 ± 7.98 | 71.29 ± 7.76 | 72.19 ± 8.51 | 1.239 | 0.216 |
ALB (g/L), mean ± SD | 40.75 ± 6.14 | 40.83 ± 6.07 | 40.52 ± 6.34 | -0.551 | 0.582 |
SI (μmol/L), mean ± SD | 22.36 ± 10.67 | 22.37 ± 10.15 | 22.33 ± 11.97 | -0.040 | 0.968 |
SF (ug/L), median (IQR) | 165.00 (70.25, 303.25) | 163.00 (76.00, 304.00) | 174.00 (54.50, 295.00) | -0.721 | 0.471 |
TRF (g/L), mean ± SD | 2.75 ± 0.89 | 2.75 ± 0.91 | 2.76 ± 0.83 | 0.203 | 0.840 |
TSH (mIU/L), median (IQR) | 1.85 (1.33, 2.83) | 1.94 (1.30, 2.89) | 1.72 (1.34, 2.66) | -1.435 | 0.151 |
FT4 (pmol/L), mean ± SD | 17.10 ± 14.18 | 17.31 ± 9.77 | 16.57 ± 9.62 | -0.698 | 0.485 |
FT3 (pmol/L), mean ± SD | 4.98 ± 1.00 | 5.01 ± 1.02 | 4.90 ± 0.94 | -1.245 | 0.214 |
ALT (IU/L), median (IQR) | 33.20 (19.40, 78.57) | 32.20 (19.10, 76.57) | 34.75 (19.65, 79.25) | -0.610 | 0.542 |
AST (IU/L), median (IQR) | 33.75 (22.35, 72.47) | 33.75 (22.02, 65.60) | 34.10 (22.62, 78.75) | -0.491 | 0.624 |
GGT (IU/L), median (IQR) | 53.85 (24.35, 116.77) | 54.55 (24.97, 100.57) | 50.05 (22.07, 163.45) | -0.274 | 0.708 |
- Citation: Li YQ, Kuai WT, Chen L, Zeng MH, Tao XM, Han JX, Wang YK, Xu LX, Ge LY, Liu YG, Li S, Xu L, Mi YQ. Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram. World J Gastroenterol 2025; 31(2): 99082
- URL: https://www.wjgnet.com/1007-9327/full/v31/i2/99082.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i2.99082